ONCOTYPE DX.
Prescriptive
About This Test
Oncotype DX is an advanced genomic test used in patients with early-stage breast cancer to analyze the activity of specific cancer-related genes within the tumor tissue. The test generates a Recurrence Score® that helps predict the risk of cancer returning and assists doctors in determining whether
TISSUE
Results
552 hours
Fasting
Fasting is not required
Price
Starting ₹350000
Age Category
18-60
Who Should Book This Test?
Individuals diagnosed with early-stage, hormone receptor-positive (HR+), HER2-negative breast cancer who need guidance on treatment planning. Patients and oncologists seeking to understand the risk of cancer recurrence and the potential benefit of chemotherapy. Those looking for a personalized, genomics-based approach to breast cancer treatment decisions, helping avoid unnecessary therapies where appropriate.
Sabhi Labs, Sahi Price
Chat with Dr. Curelo
Home Sample Collection
Smart AI Reports
Your Cart
No items in cart